Home   ›   Stakeholders   ›   MA Holders

Marketing Authorisation Holders

MAH obligations in line with Directive 2011/62/EU (Falsified Medicines Directive)

From 9th February 2019 most prescription medicines placed on the market in Europe need to have safety features in the form of unique identifiers and anti-tamper devices. These requirements are set out in the Directive 2011/62/EU (Falsified Medicines Directive) and the Commission Delegated Regulation (EU) 2016/161. Marketing Authorisation Holders (MAHs) must also register with the national organisations in charge of setting up the system.
For more information please read Letter to Stakeholders.

Onboarding to EMVO

On-Boarding Partners (Original Pack Manufacturers and Parallel Distributors) need to onboard to the EU Hub which is managed by EMVO. For detailed information regarding the EMVO onboarding process which has both contractual and technical elements, please visit EMVO website or read EMVO Onboarding Guideline.
Also, unique identifier data on the packs must be uploaded to EU Hub. The data will then transfer from the EU Hub to the national repository for the market where the packs are intended to be sold.

Onboarding to CMVO

In Croatia the national system is set up and managed by the Croatian Medicines Verification Organisation (CMVO). The MAH onboarding to CMVO includes signing of Participation Agreement and payment of fees. To start with the onboarding process, please contact us at .


The Regulation states that the pharmaceutical industry is responsible for the co-financing CMVO costs such as the costs for developing, implementing, operating and maintaining the CMVS, the costs for connecting the CMVS to the European Hub, any costs charged to CMVO by EMVO, etc.
MAHs contribute to the coverage of the above mentioned costs with:
– a one-off Registration Fee into the Program (“registration into the Program”), which is HRK 50,000.00 for new MAHs
– an Annual Fee in the amount of HRK 53,000.00 for the year 2019
– an Annual Fee in the amount of HRK 50,000.00 for the year 2020


Letter to stakeholders

A key measure to address falsification in the EU and protect the legal supply chain of medicines is an end-to-end verification system introduced by the Falsified Medicines Directive (FMD).

Read more

Amount of the annual fee

HOPAL determined the amount of the annual fee for the Croatian Medicines Verification System usage by MAHs
Read more


The Croatian Medicines Verification Organisation (HOPAL) is a non-profit organisation representing the different stakeholders, both...
Read more

Contact Us

If you have any questions or need some information, we will gladly communicate with you via or via the following contact form. To successfully reply to your message, please, fill out all contact form fields and enter the summation result into the 'captcha' field to protect against spam messages:

14 + 13 =

© 2018 HOPAL

Croatian Medicines Veryfication Organization
Radnička 80, 10000 Zagreb, Croatia
T +385 (0)1 5625 759
F +385 (0)1 5625 760